Ibrahim Yakoub‐Agha

25.7k total citations · 2 hit papers
407 papers, 7.6k citations indexed

About

Ibrahim Yakoub‐Agha is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ibrahim Yakoub‐Agha has authored 407 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 279 papers in Hematology, 130 papers in Oncology and 92 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ibrahim Yakoub‐Agha's work include Hematopoietic Stem Cell Transplantation (220 papers), Acute Myeloid Leukemia Research (120 papers) and Acute Lymphoblastic Leukemia research (79 papers). Ibrahim Yakoub‐Agha is often cited by papers focused on Hematopoietic Stem Cell Transplantation (220 papers), Acute Myeloid Leukemia Research (120 papers) and Acute Lymphoblastic Leukemia research (79 papers). Ibrahim Yakoub‐Agha collaborates with scholars based in France, Germany and Spain. Ibrahim Yakoub‐Agha's co-authors include Mohamad Mohty, Nicolaus Kröger, Myriam Labopin, Philippe Moreau, Mauricette Michallet, Didier Blaise, Régis Peffault de Latour, Nöel Milpied, Valérie Coiteux and Jordan Gauthier and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Ibrahim Yakoub‐Agha

373 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

2021 223 citations Jakob Passweg, Helen Baldomero et al. Bone Marrow Transplantation profile →
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

2022 159 citations John A. Snowden, Isabel Sánchez‐Ortega et al. Bone Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ibrahim Yakoub‐Agha France	47	4.7k	2.8k	1.6k	1.4k	1.3k	407	7.6k
Benedetto Bruno Italy	51	5.5k 1.2×	2.6k 0.9×	2.1k 1.3×	1.6k 1.2×	1.0k 0.8×	278	8.0k
Chitra Hosing United States	51	5.1k 1.1×	3.2k 1.1×	2.2k 1.3×	1.3k 0.9×	1.2k 0.9×	372	8.9k
Daniel R. Couriel United States	45	4.7k 1.0×	1.8k 0.6×	1.9k 1.2×	795 0.6×	1.1k 0.9×	155	6.6k
Bipin N. Savani United States	51	5.9k 1.2×	3.0k 1.1×	2.7k 1.6×	1.1k 0.8×	1.9k 1.5×	365	9.0k
Mauricette Michallet France	50	6.9k 1.5×	2.6k 0.9×	1.8k 1.1×	2.0k 1.4×	1.9k 1.5×	311	10.0k
Salut Brunet Spain	45	4.2k 0.9×	1.6k 0.6×	1.1k 0.7×	1.8k 1.3×	1.4k 1.1×	201	6.7k
Renato Fanin Italy	42	3.6k 0.8×	2.0k 0.7×	1.2k 0.7×	1.4k 1.0×	705 0.6×	226	6.6k
Donald Bunjes Germany	48	3.8k 0.8×	1.9k 0.7×	2.5k 1.5×	933 0.7×	1.1k 0.9×	221	7.7k
Karen K. Ballen United States	45	5.8k 1.2×	2.1k 0.7×	1.9k 1.2×	1.0k 0.7×	1.8k 1.4×	234	8.1k
Michael B. Maris United States	50	7.8k 1.7×	2.8k 1.0×	2.5k 1.5×	1.2k 0.9×	2.3k 1.8×	173	11.0k

Countries citing papers authored by Ibrahim Yakoub‐Agha

Since Specialization

Citations

This map shows the geographic impact of Ibrahim Yakoub‐Agha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Yakoub‐Agha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Yakoub‐Agha more than expected).

Fields of papers citing papers by Ibrahim Yakoub‐Agha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Yakoub‐Agha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Yakoub‐Agha. The network helps show where Ibrahim Yakoub‐Agha may publish in the future.

Co-authorship network of co-authors of Ibrahim Yakoub‐Agha

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Yakoub‐Agha. A scholar is included among the top collaborators of Ibrahim Yakoub‐Agha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Yakoub‐Agha. Ibrahim Yakoub‐Agha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neofytos, Dionysios, Paul E. Verweij, Diana Averbuch, et al.. (2025). Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee. Current Research in Translational Medicine. 73(3). 103509–103509.

Alsuliman, Tamim, Léonardo Magro, Marie Robin, et al.. (2024). Formation médicale en simulation au prélèvement de moelle osseuse d’un donneur sain en vue d’une allogreffe de cellules souches hématopoïétiques (SFGM-TC). Bulletin du Cancer.

Pagliuca, Simona, Christoph Schmid, Nicole Santoro, et al.. (2024). Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT. The Lancet Haematology. 11(6). e448–e458. 12 indexed citations

Conrad, Anne, Yves Béguin, Amandine Le Bourgeois, et al.. (2023). Mise à jour du calendrier vaccinal après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 111(2). S40–S49.

Yakoub‐Agha, Ibrahim, Raffaella Greco, Francesco Onida, et al.. (2023). Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplantation. 58(6). 696–700. 10 indexed citations

Faure, Emmanuel, Hélène Behal, Micha Srour, et al.. (2022). The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients. Blood Advances. 7(5). 856–865. 9 indexed citations

Passweg, Jakob, Helen Baldomero, Christian Chabannon, et al.. (2022). Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey. Bone Marrow Transplantation. 57(5). 742–752. 41 indexed citations

Chabannon, Christian, Régis Peffault de Latour, Bénédicte Neven, et al.. (2021). CAR-T cells : comment le registre de l’EBMT monitore les activités en Europe, identifie les contraintes et prépare l’évolution des régulations. Bulletin du Cancer. 108(10). S155–S161. 2 indexed citations

Beauvais, David, Séverine Loridant, Rémy Nyga, et al.. (2021). Potential role of tocilizumab in severe gastrointestinal barrier damage after CAR T-cell therapy. Journal of Microbiology Immunology and Infection. 54(2). 327–330. 7 indexed citations

10.

Ljungman, Per, Małgorzata Mikulska, Rafael de la Cámara, et al.. (2020). Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplantation. 56(3). 755–755. 11 indexed citations

11.

Baron, Frédéric, Myriam Labopin, Didier Blaise, et al.. (2020). Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT. Bone Marrow Transplantation. 56(2). 461–469. 2 indexed citations

12.

Penack, Olaf, Christophe Peczynski, Mohamad Mohty, et al.. (2020). How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Advances. 4(24). 6283–6290. 102 indexed citations

13.

Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2019). Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT. Haematologica. 105(2). 414–423. 8 indexed citations

14.

Pugnet, G., Mathieu Puyade, Louis Terriou, et al.. (2017). Indications et suivi des autogreffes de cellules souches hématopoïétiques dans les maladies auto-immunes et auto-inflammatoires : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 104(12). S169–S180. 13 indexed citations

15.

Cornillon, Jérôme, Flore Sicre de Fontbrune, Sylvain Chantepie, et al.. (2016). Dysfonctionnement du greffon et érythroblastopénie après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 103(11). S248–S254. 3 indexed citations

16.

Yakoub‐Agha, Ibrahim, et al.. (2016). Considérations générales et éthiques pour le recueil d’un consentement éclairé : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 103(11). S207–S212. 3 indexed citations

17.

Rubio, Marie Thérèse, A Charbonnier, Eva de Berranger, et al.. (2013). Vaccinations post-allogreffe de cellules souches hématopoïétiques : lesquels ? Quand ? Comment ?. Pathologie Biologie. 61(4). 139–143. 9 indexed citations

18.

Yakoub‐Agha, Ibrahim, et al.. (2010). Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse. Bone Marrow Transplantation. 45(10). 1546–1552. 82 indexed citations

19.

Gouill, Steven Le, Nöel Milpied, Agnès Buzyn, et al.. (2008). Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire. Journal of Clinical Oncology. 26(14). 2264–2271. 208 indexed citations

20.

Yakoub‐Agha, Ibrahim, Mathieu Kuentz, Norbert Ifrah, et al.. (2006). Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen–Identical Siblings Versus Human Leukocyte Antigen–Allelic–Matched Unrelated Donors (10/10) in Patients With Standard-Risk Hematologic Malignancy: A Prospective Study From the French Society of Bone Marrow Transplantation and Cell Therapy. Journal of Clinical Oncology. 24(36). 5695–5702. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact